• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Drug Policy and Law
  • Harm Reduction
  • Activism

Drugreporter

News and Films from the Frontline of the War on Drugs

  • News
  • Café
  • Videos
  • About Us
  • EN
    • HU
    • RU

Hungary: Risky Substances and Dangerous Drug Policies

February 1, 2007 | Author: Kardos Tamás

Tweet

HCLU won a Freedom of information lawsuit against the Hungarian Ministry of Health for withholding a position paper on the dangerousness of illicit substances. After receiving the document HCLU issued a comprehensive study as a critique.HCLU won a Freedom of information lawsuit against the Hungarian Ministry of Health for withholding a position paper on the dangerousness of illicit substances. After receiving the document HCLU issued a comprehensive study as a critique.

The Hungarian Civil Liberties Union won a Freedom of information lawsuit against the Hungarian Ministry of Health for withholding a position paper on the dangerousness of illicit substances, written by the Hungarian Expert Association of Psychiatry and the Expert Association of Neurology. HCLU has written a 95 page long study on the 7 page long position paper of the Associations, gaining interest both in the media and among experts. The Ministry may reconsider categorization of illicit substances, on which the minimum penalties in the field of illicit drug trafficking are planned to be based.

 

In 2004 the European Council ordered the Member States to lay down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking, with the aim of developing a common EU level approach. The Framework Decision[1] called for “effective, proportionate and dissuasive” penalties, taking into account among others “factual elements such as the quantities and the type of drugs trafficked”.

 

As Hungarian drug laws yet do not classify illicit substances according to their dangers, the Ministry of Health requested a position paper on the categorization of illicit substances from the Expert Associations of Psychiatry and Neurology. The HCLU showed interest and asked for the paper, but both the Associations and the Ministry have refused to give it out. HCLU has sued the Ministry of Health, and after an almost one year long process, the court ordered the Ministry to give it out.

 

HCLU staff was surprised as it contained not more that 3.5 pages with 4 pages of bibliography. HCLU has issued a brief press release saying it does not provide evidence base for legal decisions, as it is more like a one sided ideological pamphlet with moralizing, scientifically unproven or at best debated claims. HCLU staff discovered that one third of the document was the slightly changed translation of the abstract of a Swedish clinical psychologists’ article.[2] Although the press later interpreted so, HCLU did not state that this was plagiarism, but raised its concern on scientific exhaustiveness. Objectiveness was also a question since the author is a member of the radical prohibitionist organization, Europe Against Drugs[3].

 

As an answer to the Position Paper, HCLU has issued a comprehensive study.[4] It contained scientific analysis of various drug related claims of the Associations, and the review of the international literature on drug categorization.

 

Some weeks after the study was released, the Ministry of Health initiated a public consultation process with various professional organizations – including HCLU – on the possibilities of developing a classification system for illicit substances. This means that our campaign was successful in generating a social dialogue on this question.

 

The most important conclusions of the study are the following, presented in the form of a Fact Sheet.

 

1. Criticism of the statements of the Associations

 

Cannabis and memory decay: it is not proven that the long, intensive use of marijuana causes as significant and permanent damage in cognition, perception and memory like the long, intensive use of alcohol;

 

Cannabis and amotivational syndrome: heavy users of marijuana who are under the influence of acute marijuana intoxication regularly may feel less motivation for everyday activities but marijuana itself has no chronic effect which causes the loss of motivation and energy in the longer run;

 

Cannabis and stroke: there are very few existing research in this area but it is very unprobable that cannabis contributes significantly to the development of stroke;

 

Ecstasy and brain damage: the occasional use of MDMA does not lead to the damage of the nervous system, there is a detectable damage in cognitive functions of regular users but it is detectable only with very sensitive tests and does not effect everyday living.

 

2. The dangerousness of psychoactive substances

 

Risk and hazard: the dangerousness of a given drug can be assessed only with the thorough analysis of the set and setting of use, social and health characteristics of the user. The actual hazard of drug use is consisted of various risk factors which can change with the environment and the user. 

 

Drug-specific and system-specific risk: we have to differentiate the risk which is the characteristic of the use of a substance in itself from the risk connected to the social and political context of the use;

 

Perceived and real risk: often there is a big gap between risk perceived by society and the risk proven by scientific research. There are several everyday activities which can be much more dangerous than the real risks from the use of many illicit drugs – however, their perceived risk is relatively low;

 

Danger and crime: drug related harms usually cannot be reduced by simple repressive measures which are sometimes counterproductive. The controlled, limited legal access to drugs can minimalize these harms.

 

The report therefore recommends to find an alternative policy option between criminal prohibition and free market legalization of drugs. The aims of this new control system is:

 

•to regulate, limit and control the access to different mind altering drugs. 

•to provide wide access to social and health programs intending to reduce drug related harms and prevent drug abuse;

•to fight black market with effective law enforcement interventions

 

HCLU

1 February 2007



[1]  Council Framework Decision 2004/757/JHA of 25 october 2004 laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking URL:http://href.hu/x/28in

[2] Lundqvist T. (2005) Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav. 2005 Jun;81(2):319-30. URL: http://href.hu/x/1z13

[3] URL: http://www.eurad.net

[4] Risky Substances and Dangerous Drug Policies, Ed.: Peter Sarosi, HCLU, 2007, Budapest (only in Hungarian) URL: http://href.hu/x/27u2

Filed Under: Articles Topics: Drug Policy and Law

Access to this article is free - but to produce articles and videos is not. Drugreporter is a non-profit website that needs your support to provide you with high quality contents.

Become a supporter and make a donation of 5 $ today!

Kapcsolódó cikkek:

The Italian Anti-Rave Law Violates Human Rights – Interview with Susanna Ronconi

February 1, 2023 - Péter Sárosi

Decriminalisation in Portugal: Through the Lens of People who Use Drugs

December 5, 2022 - István Gábor Takács

Drugreporter News | 2022 November

November 24, 2022 - István Gábor Takács

Kapcsolódó videók:

Decriminalisation in Portugal: Through the Lens of People who Use Drugs

December 5, 2022 - István Gábor Takács

Drugreporter News | 2022 November

November 24, 2022 - István Gábor Takács

Harm Reduction in Athens – With the Eye of an Outsider

November 23, 2022 - Péter Sárosi

You can browse our topics here:

Activism COVID-19 Criminalisation Dose of Science Drug Consumption Rooms Drug Policy and Law European Drug Policy Harm Reduction Hepatitis HIV/AIDS Marijuana Policies Medical Marijuana Needle and syringe programs New Psychoactive Substances Opiate Substitution Overdose Prevention Psychedelic Medicines Regulation and Control Russian Drug Policy Sex Work United Nations Drug Policy US Drug Policy

Primary Sidebar

BECOME A SUPPORTER OF DRUGREPORTER! INVEST THE PRICE OF A COFFEE MONTHLY AND MAKE SURE DRUGREPORTER KEEPS RUNNING!
Subscribe to the Newsletter!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
  • Facebook
  • Twitter
  • YouTube

Search

Drugreporter Video Database

Hundreds of videos on drug policy, harm reduction and human rights for streaming and download, also on a world map!

DRUGREPORTER NEWS

Monthly drug policy news from around the world

Drugreporter café

In our new online video show, we regularly discuss new developments in the world of drug policy with professionals, activists and decision makers. You can also listen to the Drugreporter Café in Podcast format on Spotify or Apple Podcasts!

COVID-19 Harm Reduction Update

On this info page Drugreporter provides regular updates about resources and news on how harm reduction service providers respond to the COVID-19 Epidemic.

Drugreporter Video Advocacy Network

Browse videos produced by members of our Drugreporter Video Advocacy Network, from all around the world!

DRUG USERS NEWS

Russian language videos on drug policy, harm reduction and human rights.

Our award winning animated documentary movie is based on the original audio recording of Kostya Proletarsky, a drug user and HIV activist who died as a result of mistreatment and torture at a Russian prison. Festival appearances, news and resources are available here!

Footer

Rights Reporter Foundation
Hungary, 1032 Budapest
San Marco Street 70.
Email: rightsreporter@rightsreporter.net

Search

Our other websites:

The Rights Reporter Foundation

The Autocracy Analyst

Room for Change Campaign

Room in the 8th District Campaign

A Day in the Life movie website

Drugreporter